Anteilseigner
Frazier Life Sciences Management LP (13,93 %) Eventide Asset Management LLC (5,71 %) The Vanguard Group, Inc. (5,14 %) BlackRock Fund Advisors (4,86 %) NEA Management Co. LLC (4,69 %) Janus Henderson Investors US LLC (4,39 %) Deerfield Management Co. LP (Private Equity) (4,36 %) Cadian Capital Management LP (4,15 %) Rock Springs Capital Management LP (3,97 %) SSgA Funds Management, Inc. (3,72 %) RiverVest Venture Management LLC (3,48 %) Novo Holdings A/ S (Investment Company) (3,22 %) Citadel Advisors LLC (2,98 %) T. Rowe Price Associates, Inc. (Investment Management) (2,47 %) Avidity Partners Management LP (2,45 %) Tang Capital Management LLC (2,44 %) Franklin Advisers, Inc. (1,96 %) Medical Strategy GmbH (1,86 %) First Turn Management LLC (1,79 %)
Kontakt
Mirum Pharmaceuticals Inc.